FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mary Adrian

Research Profile

Anatomy

Procedures

Living Beings

Chemicals & Drugs

Physiology

Organ Size

Concepts & Ideas

Co-author Network

Publications

TOP 3
Owen B Wallace; Kenneth S Lauwers; Jeffrey A Dodge; Scott A May; Joel R Calvin; Ronald Hinklin; Henry Bryant; Pamela K Shetler; Mary D Adrian; Andrew G Geiser; Masahiko Sato; Burris thomas
A selective estrogen receptor modulator for the treatment of hot flushes.
Andrew G Geiser; Conrad W Hummel; Michael W Draper; Judith W Henck; Ilene R Cohen; Daniel G Rudmann; Kevin B Donnelly; Mary D Adrian; Timothy A Shepherd; Owen B Wallace; Denis J McCann; Samuel W Oldham; Henry Bryant; Masahiko Sato; Jeffrey A Dodge
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation.
Leah M Helvering; Mary D Adrian; Andrew G Geiser; Shawn T Estrem; Tao Wei; Shuguang Huang; Peining Chen; Ernst Dow; J N Calley; Jeffrey A Dodge; Timothy Grese; Scott A Jones; David L Halladay; Rebecca R Miles; Jude E Onyia; Yanfei L Ma; Masahiko Sato; Henry Bryant
Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mary Adrian (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Owen B Wallace; Kenneth S Lauwers; Jeffrey A Dodge; Scott A May; Joel R Calvin; Ronald Hinklin; Henry Bryant; Pamela K Shetler; Mary D Adrian; Andrew G Geiser; Masahiko Sato; Burris thomas
A selective estrogen receptor modulator for the treatment of hot flushes.
Journal of medicinal chemistry 2006;49(3):843-6.
2005: Andrew G Geiser; Conrad W Hummel; Michael W Draper; Judith W Henck; Ilene R Cohen; Daniel G Rudmann; Kevin B Donnelly; Mary D Adrian; Timothy A Shepherd; Owen B Wallace; Denis J McCann; Samuel W Oldham; Henry Bryant; Masahiko Sato; Jeffrey A Dodge
A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation.
Endocrinology 2005;146(10):4524-35.
2005: Leah M Helvering; Mary D Adrian; Andrew G Geiser; Shawn T Estrem; Tao Wei; Shuguang Huang; Peining Chen; Ernst Dow; J N Calley; Jeffrey A Dodge; Timothy Grese; Scott A Jones; David L Halladay; Rebecca R Miles; Jude E Onyia; Yanfei L Ma; Masahiko Sato; Henry Bryant
Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus.
Biology of reproduction 2005;72(4):830-41.
2004: Owen B Wallace; Henry Bryant; Pamela K Shetler; Mary D Adrian; Andrew G Geiser
Benzothiophene and naphthalene derived constrained SERMs.
Bioorganic & medicinal chemistry letters 2004;14(20):5103-6.
2003: Charles W Lugar; David Magee; Mary D Adrian; Pamela K Shetler; Henry Bryant; Jeffrey A Dodge
B-ring unsaturated estrogens: biological evaluation of 17alpha-Dihydroequilein and novel B-Nor-6-thiaequilenins as tissue selective estrogens.
Bioorganic & medicinal chemistry letters 2003;13(24):4281-4.
2001: Timothy Grese; Mary D Adrian; DL Phillips; Pamela K Shetler; LL Short; Andrew Glasebrook; Henry Bryant
Photochemical synthesis of N-arylbenzophenanthridine selective estrogen receptor modulators (serms).
Journal of medicinal chemistry 2001;44(17):2857-60.
1998: Masahiko Sato; C H Turner; T Wang; Mary D Adrian; ER Rowley; Henry Bryant
LY353381.HCl: a novel raloxifene analog with improved SERM potency and efficacy in vivo.
The Journal of pharmacology and experimental therapeutics 1998;287(1):1-7.
1998: Russell T Turner; Glenda L Evans; James Sluka; Mary D Adrian; Henry Bryant; C H Turner; Masahiko Sato
Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene.
Endocrinology 1998;139(9):3712-20.
1998: Timothy Grese; L D Pennington; James Sluka; Mary D Adrian; Harlan W Cole; Tina Fuson; David Magee; DL Phillips; ER Rowley; Pamela K Shetler; LL Short; M Venugopalan; NN Yang; Masahiko Sato; Andrew Glasebrook; Henry Bryant
Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.
Journal of medicinal chemistry 1998;41(8):1272-83.
1997: Timothy Grese; S Cho; Don R Finley; A G Godfrey; C D Jones; Charles W Lugar; M J Martin; K Matsumoto; L D Pennington; Mark A Winter; Mary D Adrian; Harlan W Cole; David Magee; DL Phillips; ER Rowley; LL Short; Andrew Glasebrook; Henry Bryant
Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
Journal of medicinal chemistry 1997;40(2):146-67.